Association of polymorphisms in genes regulating the corticotropin- releasing factor system with antidepressant treatment response

Association of polymorphisms in genes regulating the corticotropin- releasing factor system with antidepressant treatment response

10.1001/archgenpsychiatry.2010.18

Saved in:

Bibliographic Details
Main Authors:	Binder, E.B., Owens, M.J., Liu, W., Deveau, T.C., Rush, A.J., Trivedi, M.H., Fava, M., Bradley, B., Ressler, K.J., Nemeroff, C.B.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/109939
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Relationship between obesity and depression: Characteristics and treatment outcomes with antidepressant medication
by: Toups, M.S.P., et al.
Published: (2014)

Corticotropin releasing factor (CRF) in the hippocampus of the mouse pilocarpine model of status epilepticus
by: Wu, J., et al.
Published: (2014)

Association of Cholecystokinin-2 and corticotropin-releasing factor receptor with mood and anxiety disorders
by: TESSI SHERRIN
Published: (2014)

Corticotropin-releasing factor induces functional and structural synaptic remodelling in acute stress
by: Vandael, Dorien, et al.
Published: (2022)

Cushing's Syndrome Caused by Ewing's Sarcoma Secreting Corticotropin Releasing Factor-Like Peptide
by: Chawalit Preeyasombat, et al.
Published: (2018)

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression
by: Ising, M., et al.
Published: (2014)

Activation of corticotropin-releasing factor receptor 1 selectively inhibits CaV3.2 T-type calcium channels
by: Tao, J., et al.
Published: (2011)

A practical approach to the early identification of antidepressant medication non-responders
by: Li, J., et al.
Published: (2014)

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the sequenced treatment alternatives to relieve depression (STAR*D) study
by: Kornstein, S.G., et al.
Published: (2014)

Ultrastructural study of phenylethanolamine-N-methyltransferase, corticotropin-releasing factor and neurotensin immunoreactive neurons in the external cuneate nucleus of the gerbil
by: Lan, C.-T., et al.
Published: (2015)

Ultrastructural study of phenylethanolamine-N-methyltransferase, corticotropin-releasing factor and neurotensin immunoreactive neurons in the external cuneate nucleus of the gerbil
by: Lan, C.-T., et al.
Published: (2016)

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: An exploratory report from the combining medications to enhance depression outcomes study
by: Zisook, S., et al.
Published: (2014)

Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
by: Davis, L.L., et al.
Published: (2014)

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
by: Sung, S.C., et al.
Published: (2014)

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
by: McClintock, S.M., et al.
Published: (2014)

Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies
by: Uher, R., et al.
Published: (2014)

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
by: Sung, S.C., et al.
Published: (2014)

Activation of corticotropin-releasing factor 2 receptor inhibits Purkinje neuron P-type calcium currents via Goα-dependent PKC epsilon pathway
by: Tao, J., et al.
Published: (2014)

Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
by: Cutler, J.A., et al.
Published: (2014)

The effectiveness of antidepressant monotherapy in a naturalistic outpatient setting
by: Lee, T.-S., et al.
Published: (2014)

Adherence to antidepressant combinations and monotherapy for major depressive disorder: A CO-MED report of measurement-based care
by: Warden, D., et al.
Published: (2014)

Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect
by: Srisurapanont M., et al.
Published: (2014)

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
by: Bobo, W.V., et al.
Published: (2014)

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
by: Seetal Dodd, et al.
Published: (2018)

Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?
by: Joseph Goldberg, et al.
Published: (2018)

Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings
by: Athreya, Arjun P., et al.
Published: (2022)

Lipidomic analyses of the mouse brain after antidepressant treatment: Evidence for endogenous release of long-chain fatty acids?
by: Lee, L.H.-W., et al.
Published: (2011)

Lipidomic analyses of the mouse brain after antidepressant treatment: Evidence for endogenous release of long-chain fatty acids?
by: Lee, L.H.-W., et al.
Published: (2011)

Lipidomic analyses of the mouse brain after antidepressant treatment: Evidence for endogenous release of long-chain fatty acids?
by: Lee, L.H.-W., et al.
Published: (2011)

Antidepressants for children with depression
by: Sirichai Hongsanguansri
Published: (2018)

Duration of initial antidepressant treatment and subsequent relapse of major depression
by: Baldessarini R.J, et al.
Published: (2016)

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
by: Gaynes, B.N., et al.
Published: (2014)

Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder
by: Korgaonkar M.S., et al.
Published: (2016)

Ketamine Antidepressant : Breakthrough or Potential Hazard?
by: Tan, Teck Boon, et al.
Published: (2018)

Clinicallyrelevant anticancer-antidepressant drug interactions
by: Chan, A., et al.
Published: (2014)

Frontal white matter anisotropy and antidepressant remission in late-life depression
by: Taylor, W.D., et al.
Published: (2014)

What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
by: Gollan, J.K., et al.
Published: (2014)

Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
by: Braund, Taylor A., et al.
Published: (2022)

Clinical Use of Mood Stabilizers With Antidepressants in Asia Report From the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD) Projects in 2004 and 2013
by: Kamini Rajaratnam, et al.
Published: (2017)

Use of antidepressants among Finnish family caregivers: a nationwide register-based study
by: Mikkola, Tuija M., et al.
Published: (2022)